Angelique Lucien is a Research Coordinator at Radial, where she leads clinical research focused on advancing innovative treatments in psychiatry and brain health. Her work involves coordinating research studies, engaging participants throughout the research process, ensuring regulatory compliance, and contributing to the collection of high-quality clinical data that helps improve treatment outcomes.

‍

Her background includes work on various studies across companies such as Pfizer and Johnson & Johnson, spanning several infectious disease departments. This includes trials such as the pediatric COVID vaccine trial, as well as studies on monkeypox and Lyme disease.  She also worked on SAINT trial in its early days, and more recently on the Brainsway SWIFT trial.

‍

Outside of work, Angelique enjoys traveling, spending time with family and friends, trying new restaurants, and staying active.  She is driven by a curiosity about the brain and a commitment to improving the lives of individuals affected by mental illness through research and innovation.

‍